C50
Conditions
Interventions
Group 1: Patients receive a weekly PRO survey via smartphone app which triggers an alarm to the treating breast cancer center in case of worsening values. They will be contacted by their treating ph
Sponsors
Charité - Universitätsmedizin Berlin
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Women - with metastatic breast cancer, - who are treated in a participating breast cancer center, - who are insured with one of the following health insurance companies: BARMER, DAK Gesundheit, BKK-VBU*, - who are able to consent, - who are older than 18, - who are receiving drug treatment for metastatic breast cancer, - who have a life expectancy of more than 3 months at enrollment, - who are classified as ECOG 0-2, - who are willing to participate in a weekly, online-based PRO survey, - and who have access to the internet (smartphone, tablet) may be included. *after extension of the legal basis, participation is temporarily possible for patients of other health insurance companies
Exclusion criteria
Exclusion criteria: Patients who do not receive active cancer therapy (comfort care) or who do not meet all of the inclusion criteria are not eligible to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint of the study is fatigue at 6 months, measured with a study-specific questionnaire consisting of items from the EORTC CAT item bank via a smartphone app | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are overall survival, unplanned medical consultations, hospitalizations and emergency room visits. | — |
Countries
Germany
Outcome results
None listed